Benazepril Hydrochloride and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Benazepril Hydrochloride and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | benazepril hydrochloride and hydrochlorothiazide |
SUBSTANCE NAME: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-02-11 |
END MARKETING DATE: | 0000-00-00 |
Benazepril Hydrochloride and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
Item Description | Benazepril Hydrochloride and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5; 6.25(mg/1; mg/1) |
START MARKETING DATE: | 2004-02-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-4725_5b743a7d-e3a9-4524-8928-c3eec397922c |
PRODUCT NDC: | 0378-4725 |
APPLICATION NUMBER: | ANDA076688 |
Other BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: